EGR3 and breast cancer: We further compared the mRNA levels of these six rhythm genes between 20 normal breast tissues and 20 breast cancer tissues by using qPCR and confirmed that the aberrant expression of NFIL3 and EGR3 in breast cancer is consistent with the results from the GEPIA database (Fig. 1B).